ActiPatch Muscle and Joint Pain Therapy Device

Product Information

Read more at http://www.bielcorp.com/bioelectronics-wins-high-commendation-most-innovative-otc-product-award-otc-bulletin/ ActiPatch® Pain Relief Therapy Featured on Leading Healthcare Show in Spain A panel of six independent over-the-counter marketing experts evaluated all twelve nominees from some of the world’s leading pharmaceutical companies. One of the judges, Jerome Reinsten, former Director-General of the World Self-Medication Industry, remarked that ActiPatch Therapy was a “novel and previously unexplored route to topical pain therapy,” while another judge felt the product range was an “ingenious way of providing pain relief.” disaggregation of the mucopolysaccharides of ground substance which causes its increased fluidity and is one of the earliest features of the inflammatory Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289):2082-2097. doi: 10.1016/S0140-6736(21)00393-7. PMID: 34062143. Primary care prescribers are advised not to take on prescribing of these medicines unless they have been adequately informed by letter of their responsibilities with regards monitoring, side effects and interactions and are happy to take on the prescribing responsibility. A copy of locally approved shared care guidelines should accompany this letter which outlines these responsibilities. Primary care prescribers should then tell secondary care of their intentions as soon as possible by letter so that arrangements can be made for the transfer of care.

Treede R-D, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain. 2015 Jun;156(6):1003-1007. doi: 10.1097/j.pain.0000000000000160. PMID: 25844555; PMCID: PMC4450869. Unfortunately, the good it is doing is being ignored. The financial side of it especially is just amazing. Rawe IM, Kotak DC. A UK registry study of the effectiveness of a new over-the-counter chronic pain therapy. Pain Manag. 2015;5(6):413-423. doi: 10.2217/PMT.15.35. Epub 2015 Aug 3. PMID: 26235410.Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. ActiPatch works by sending out electromagnetic signal pulses into the area where you experience pain. It sends out 1,000 pulses every second, stimulating the neuromodulation of your nerves dampening the feeling of pain with every pulse. It does all this without creating any feeling of vibration, heat, or any other uncomfortable sensation which you may experience with other drug-free pain relief.

But Gary claims he has tried and failed to get the drug free alternative on the NHS despite it being available for prescription since April 2018. If you’re new to Actipatch and aren’t sure which version of this product is the best for you, there are 4 options you can choose from. Each one works in the same way, but maybe easier to use on different areas of the body: NHS England said it was unable to comment on individual prescriptions but although Actipatch is available for prescription through the national drug tariff, products have not been subject to a technology appraisal by NICE.Below are the segments from the March 26 Clear Channel Business Talk Radio interview with BioElectronics CEO Andrew Whelan: